NASDAQ:NRBO
NeuroBo Pharmaceuticals, Inc. Stock News
$4.13
+0.155 (+3.90%)
At Close: May 24, 2024
NRBO Stock Price Increases Over 5% Pre-Market: Why It Happened
08:45am, Wednesday, 24'th Mar 2021
The stock price of NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO) increased by over 5% pre-market. This is why it happened.
NeuroBo Pharmaceuticals Receives Approval for Amendment of Contingent Value Rights for Gemcabene
08:00am, Wednesday, 24'th Mar 2021
BOSTON, March 24, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced that it has received approval of an amendment to its Contin
NeuroBo Pharmaceuticals Closes $10.0 Million Private Placement
04:05pm, Thursday, 21'st Jan 2021
BOSTON, Jan. 21, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced the closing of its previously announced private placement of
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program
08:30am, Wednesday, 06'th Jan 2021
BOSTON, Jan. 6, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced that on December 31, 2020 it acquired ANA Therapeutics, a pri
NeuroBo Pharmaceuticals (NRBO) Surges: Stock Moves 5.2% Higher
09:47am, Friday, 18'th Dec 2020
NeuroBo Pharmaceuticals (NRBO) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
NeuroBo Pharmaceuticals Reports Third Quarter 2020 Financial Results
04:30pm, Friday, 13'th Nov 2020
BOSTON, Nov. 13, 2020 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying thera
NeuroBo Pharmaceuticals Reports Second Quarter 2020 Financial Results
07:00pm, Tuesday, 11'th Aug 2020
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiom
Hargreaves Lansdown: Double-Digit EPS Growth In FY20; Reiterating Buy (OTCMKTS:HRGLF)
03:55pm, Monday, 10'th Aug 2020
Hargreaves Lansdown is the #1 U.K. consumer investment platform, with more than 40% market share and customer retention exceeding 90%.
Professional Diversity Network, Inc. Announces Partnership with Web Scribble
01:22pm, Wednesday, 05'th Aug 2020
Professional Diversity Network, Inc. (NASDAQ: IPDN), (“PDN” or the “Company”), a global developer and operator of online and in-person networks that provide
Legrand: Total Number of Shares and Voting Rights
12:00am, Monday, 03'rd Aug 2020
Regulatory News: Legrand (Paris:LR): Date Total number of shares composing the share capital Total number of voting rights July 31, 2020 267,447,746 T
Legrand: Total Number of Shares and Voting Rights
12:00am, Friday, 03'rd Jul 2020
Regulatory News: Legrand (Paris:LR): Date Total number of shares composing the share capital Total number of voting rights June 30, 2020 267,447,746 T
J.D. Irving, Limited 2019 Sustainability Report Released
07:07pm, Tuesday, 30'th Jun 2020
J.D. Irving, Limited (JDI) has released its 2019 Sustainability Report for its Forestry and Forest Products Operations.
The company's sustainability framework
Riksbank Preview: Five major banks expectations | Forex Crunch
12:37pm, Tuesday, 30'th Jun 2020
The Riksbank will announce its Interest Rate Decision on 1 July at 07:30 GMT. The market consensus is for the Riksbank to stay on hold and as we get
NSE Lists LAPO Microfinance Bank’s N6.2billion bond | Nairametrics
11:20am, Tuesday, 30'th Jun 2020
NSE Lists LAPO Microfinance Bank’s N6.2billion bond Stock Market
Coquitlam, British Columbia, Jun 30, 2020 - (ACN Newswire) - Captiva Verde Land Corp. (CSE: PWR) (the "Company") is extremely pleased to announce that Solargram Farms Corporation ("Sola
